Omeros (OMER) Operating Margin Growth (3y) (2013 - 2022)

Omeros (OMER) Operating Margin Growth (3y) (2013 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 9,942.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -1,211.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 7,794.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Omeros 707.67 Mn 707.67 Mn 9.31 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 -33,570.00
Mar 31, 2022 -41,261.00
Dec 31, 2021 13,759.00
Sep 30, 2021 63,640.00
Jun 30, 2021 169,173.00
Mar 31, 2021 152,860.00
Dec 31, 2020 -21,544.00
Sep 30, 2020 -7,378.00
Jun 30, 2020 -13,497.00
Mar 31, 2020 322.00
Dec 31, 2019 2,095.00
Sep 30, 2019 6,945.00
Jun 30, 2019 7,434.00
Mar 31, 2019 17,385.00
Dec 31, 2018 18,635.00
Sep 30, 2018 -17,690.00
Jun 30, 2018 -134,897.00
Mar 31, 2018 287,749.00
Dec 31, 2017 1.10 Mn
Sep 30, 2017 798,201.00